Radimmune Therapeutics
David is a co-founder of Radimmune, a recognized expert in clinical radiation oncology, and a driving force behind the development of radioimmunotherapy targeting centrin-1. He is a clinical instructor at the David Geffin School of Medicine at UCLA, where he also completed his own medical and specialty training.
This person is not in the org chart
This person is not in any offices